SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Seto W.K., Lai C.L., Fung J., Hung I., Yuen J., Young J., Wong D.K., Yuen M.F. (2010) Natural history of chronic hepatitis C: Genotype 1 versus genotype 6. J Hepatol.
  • 2
    Conry-Cantilena C., Vanraden M., Gibble J., Melpolder J., Shakil A.O., Viladomiu L., Cheung L., Dibisceglie A., Hoofnagle J., Shih J.W., Kaslow R., Ness P., Alter H.J. (1996) Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. N Engl J Med 334: 16916.
  • 3
    Alter M.J., Kruszon-Moran D., Nainan O.V., Mcquillan G.M., Gao F., Moyer L.A., Kaslow R.A., Margolis H.S. (1999) The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 341: 55662.
  • 4
    Brown R.S. (2005) Hepatitis C and liver transplantation. Nature 436: 9738.
  • 5
    Shepard C.W., Finelli L., Alter M.J. (2005) Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 5: 55867.
  • 6
    Penin F., Dubuisson J., Rey F.A., Moradpour D., Pawlotsky J.M. (2004) Structural biology of hepatitis C virus. Hepatology 39: 519.
  • 7
    Moradpour D., Penin F., Rice C.M. (2007) Replication of hepatitis C virus. Nat Rev Microbiol 5: 45363.
  • 8
    Bartenschlager R., Lohmann V. (2000) Replication of hepatitis C virus. J Gen Virol 81: 163148.
  • 9
    El-Farrash M.A., Aly H.H., Watashi K., Hijikata M., Egawa H., Shimotohno K. (2007) In vitro infection of immortalized primary hepatocytes by HCV genotype 4a and inhibition of virus replication by cyclosporin. Microbiol Immunol 51: 12733.
  • 10
    Lohmann V., Korner F., Koch J., Herian U., Theilmann L., Bartenschlager R. (1999) Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285: 1103.
  • 11
    Pietschmann T., Lohmann V., Rutter G., Kurpanek K., Bartenschlager R. (2001) Characterization of cell lines carrying self-replicating hepatitis C virus RNAs. J Virol 75: 125264.
  • 12
    Windisch M.P., Frese M., Kaul A., Trippler M., Lohmann V., Bartenschlager R. (2005) Dissecting the interferon-induced inhibition of hepatitis C virus replication by using a novel host cell line. J Virol 79: 1377893.
  • 13
    Date T., Kato T., Miyamoto M., Zhao Z., Yasui K., Mizokami M., Wakita T. (2004) Genotype 2a hepatitis C virus subgenomic replicon can replicate in HepG2 and IMY-N9 cells. J Biol Chem 279: 223716.
  • 14
    Kato N., Mori K., Abe K., Dansako H., Kuroki M., Ariumi Y., Wakita T., Ikeda M. (2009) Efficient replication systems for hepatitis C virus using a new human hepatoma cell line. Virus Res 146: 4150.
  • 15
    Ali S., Pellerin C., Lamarre D., Kukolj G. (2004) Hepatitis C virus subgenomic replicons in the human embryonic kidney 293 cell line. J Virol 78: 491501.
  • 16
    Blight K.J., Mckeating J.A., Rice C.M. (2002) Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J Virol 76: 1300114.
  • 17
    Friebe P., Boudet J., Simorre J.P., Bartenschlager R. (2005) Kissing-loop interaction in the 3' end of the hepatitis C virus genome essential for RNA replication. J Virol 79: 38092.
  • 18
    Lohmann V., Korner F., Dobierzewska A., Bartenschlager R. (2001) Mutations in hepatitis C virus RNAs conferring cell culture adaptation. J Virol 75: 143749.
  • 19
    Lohmann V., Hoffmann S., Herian U., Penin F., Bartenschlager R. (2003) Viral and cellular determinants of hepatitis C virus RNA replication in cell culture. J Virol 77: 300719.
  • 20
    Krieger N., Lohmann V., Bartenschlager R. (2001) Enhancement of hepatitis C virus RNA replication by cell culture-adaptive mutations. J Virol 75: 461424.
  • 21
    Blight K.J., Mckeating J.A., Marcotrigiano J., Rice C.M. (2003) Efficient replication of hepatitis C virus genotype 1a RNAs in cell culture. J Virol 77: 318190.
  • 22
    Blight K.J., Kolykhalov A.A., Rice C.M. (2000) Efficient initiation of HCV RNA replication in cell culture. Science 290: 19724.
  • 23
    Bartenschlager R. (2005) The hepatitis C virus replicon system: from basic research to clinical application. J Hepatol 43: 2106.
  • 24
    Pietschmann T., Lohmann V., Kaul A., Krieger N., Rinck G., Rutter G., Strand D., Bartenschlager R. (2002) Persistent and transient replication of full-length hepatitis C virus genomes in cell culture. J Virol 76: 400821.
  • 25
    Kato T., Furusaka A., Miyamoto M., Date T., Yasui K., Hiramoto J., Nagayama K., Tanaka T., Wakita T. (2001) Sequence analysis of hepatitis C virus isolated from a fulminant hepatitis patient. J Med Virol 64: 3349.
  • 26
    Kato T., Date T., Miyamoto M., Furusaka A., Tokushige K., Mizokami M., Wakita T. (2003) Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon. Gastroenterology 125: 180817.
  • 27
    Wakita T., Pietschmann T., Kato T., Date T., Miyamoto M., Zhao Z., Murthy K., Habermann A., Krausslich H.G., Mizokami M., Bartenschlager R., Liang T.J. (2005) Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 11: 7916.
  • 28
    Zhong J., Gastaminza P., Cheng G., Kapadia S., Kato T., Burton D.R., Wieland S.F., Uprichard S.L., Wakita T., Chisari F.V. (2005) Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci U S A 102: 92949.
  • 29
    Lindenbach B.D., Evans M.J., Syder A.J., Wolk B., Tellinghuisen T.L., Liu C.C., Maruyama T., Hynes R.O., Burton D.R., Mckeating J.A., Rice C.M. (2005) Complete replication of hepatitis C virus in cell culture. Science 309: 6236.
  • 30
    Yi M., Ma Y., Yates J., Lemon S.M. (2007) Compensatory mutations in E1, p7, NS2, and NS3 enhance yields of cell culture-infectious intergenotypic chimeric hepatitis C virus. J Virol 81: 62938.
  • 31
    Pietschmann T., Kaul A., Koutsoudakis G., Shavinskaya A., Kallis S., Steinmann E., Abid K., Negro F., Dreux M., Cosset F.L., Bartenschlager R. (2006) Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras. Proc Natl Acad Sci U S A 103: 740813.
  • 32
    Gottwein J.M., Scheel T.K., Jensen T.B., Lademann J.B., Prentoe J.C., Knudsen M.L., Hoegh A.M., Bukh J. (2009) Development and characterization of hepatitis C virus genotype 1-7 cell culture systems: role of CD81 and scavenger receptor class B type I and effect of antiviral drugs. Hepatology 49: 36477.
  • 33
    Yi M., Villanueva R.A., Thomas D.L., Wakita T., Lemon S.M. (2006) Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells. Proc Natl Acad Sci U S A 103: 23105.
  • 34
    Yi M., Lemon S.M. (2004) Adaptive mutations producing efficient replication of genotype 1a hepatitis C virus RNA in normal Huh7 cells. J Virol 78: 790415.
  • 35
    Aly H.H., Watashi K., Hijikata M., Kaneko H., Takada Y., Egawa H., Uemoto S., Shimotohno K. (2007) Serum-derived hepatitis C virus infectivity in interferon regulatory factor-7-suppressed human primary hepatocytes. J Hepatol 46: 2636.
  • 36
    Forns X., Bukh J. (1999) The molecular biology of hepatitis C virus. Genotypes and quasispecies. Clin Liver Dis 3: 693716, vii.
  • 37
    Ikeda M., Sugiyama K., Mizutani T., Tanaka T., Tanaka K., Sekihara H., Shimotohno K., Kato N. (1998) Human hepatocyte clonal cell lines that support persistent replication of hepatitis C virus. Virus Res 56: 15767.
  • 38
    Chong T.W., Smith R.L., Hughes M.G., Camden J., Rudy C.K., Evans H.L., Sawyer R.G., Pruett T.L. (2006) Primary human hepatocytes in spheroid formation to study hepatitis C infection. J Surg Res 130: 527.
  • 39
    Molina S., Castet V., Pichard-Garcia L., Wychowski C., Meurs E., Pascussi J.M., Sureau C., Fabre J.M., Sacunha A., Larrey D., Dubuisson J., Coste J., Mckeating J., Maurel P., Fournier-Wirth C. (2008) Serum-derived hepatitis C virus infection of primary human hepatocytes is tetraspanin CD81 dependent. J Virol 82: 56974.
  • 40
    Delgado J.P., Parouchev A., Allain J.E., Pennarun G., Gauthier L.R., Dutrillaux A.M., Dutrillaux B., Di Santo J., Capron F., Boussin F.D., Weber A. (2005) Long-term controlled immortalization of a primate hepatic progenitor cell line after Simian virus 40 T-Antigen gene transfer. Oncogene 24: 54151.
  • 41
    Chen W.H., Lai W.F., Deng W.P., Yang W.K., Lo W.C., Wu C.C., Yang D.M., Lai M.T., Lin C.T., Lin T.W., Yang C.B. (2006) Tissue engineered cartilage using human articular chondrocytes immortalized by HPV-16 E6 and E7 genes. J Biomed Mater Res A 76: 51220.
  • 42
    Dimri G., Band H., Band V. (2005) Mammary epithelial cell transformation: insights from cell culture and mouse models. Breast Cancer Res 7: 1719.
  • 43
    Harms W., Rothamel T., Miller K., Harste G., Grassmann M., Heim A. (2001) Characterization of human myocardial fibroblasts immortalized by HPV16 E6–E7 genes. Exp Cell Res 268: 25261.
  • 44
    Shiga T., Shirasawa H., Shimizu K., Dezawa M., Masuda Y., Simizu B. (1997) Normal human fibroblasts immortalized by introduction of human papillomavirus type 16 (HPV-16) E6-E7 genes. Microbiol Immunol 41: 3139.
  • 45
    Akimov S.S., Ramezani A., Hawley T.S., Hawley R.G. (2005) Bypass of senescence, immortalization, and transformation of human hematopoietic progenitor cells. Stem Cells 23: 142333.
  • 46
    Watashi K., Inoue D., Hijikata M., Goto K., Aly H.H., Shimotohno K. (2007) Anti-hepatitis C virus activity of tamoxifen reveals the functional association of estrogen receptor with viral RNA polymerase NS5B. J Biol Chem 282: 3276572.
  • 47
    Murakami Y., Aly H.H., Tajima A., Inoue I., Shimotohno K. (2009) Regulation of the hepatitis C virus genome replication by miR-199a. J Hepatol 50: 45360.
  • 48
    Andrei G. (2006) Three-dimensional culture models for human viral diseases and antiviral drug development. Antiviral Res 71: 96107.
  • 49
    Aizaki H., Nagamori S., Matsuda M., Kawakami H., Hashimoto O., Ishiko H., Kawada M., Matsuura T., Hasumura S., Matsuura Y., Suzuki T., Miyamura T. (2003) Production and release of infectious hepatitis C virus from human liver cell cultures in the three-dimensional radial-flow bioreactor. Virology 314: 1625.
  • 50
    Mizumoto H., Ishihara K., Nakazawa K., Ijima H., Funatsu K., Kajiwara T. (2008) A new culture technique for hepatocyte organoid formation and long-term maintenance of liver-specific functions. Tissue Eng Part C Methods 14: 16775.
  • 51
    Funatsu K., Ijima H., Nakazawa K., Yamashita Y., Shimada M., Sugimachi K. (2001) Hybrid artificial liver using hepatocyte organoid culture. Artif Organs 25: 194200.
  • 52
    Mizumoto H., Aoki K., Nakazawa K., Ijima H., Funatsu K., Kajiwara T. (2008) Hepatic differentiation of embryonic stem cells in HF/organoid culture. Transplant Proc 40: 6113.
  • 53
    Aly H.H., Shimotohno K., Hijikata M. (2009) 3D cultured immortalized human hepatocytes useful to develop drugs for blood-borne HCV. Biochem Biophys Res Commun 379: 3304.
  • 54
    Aly H.H., Qi Y., Atsuzawa K., Usuda N., Takada Y., Mizokami M., Shimotohno K., Hijikata M. (2009) Strain-dependent viral dynamics and virus-cell interactions in a novel in vitro system supporting the life cycle of blood-borne hepatitis C virus. Hepatology 50: 68996.
  • 55
    Nishimura-Sakurai Y., Sakamoto N., Mogushi K., Nagaie S., Nakagawa M., Itsui Y., Tasaka-Fujita M., Onuki-Karakama Y., Suda G., Mishima K., Yamamoto M., Ueyama M., Funaoka Y., Watanabe T., Azuma S., Sekine-Osajima Y., Kakinuma S., Tsuchiya K., Enomoto N., Tanaka H., Watanabe M. (2010) Comparison of HCV-associated gene expression and cell signaling pathways in cells with or without HCV replicon and in replicon-cured cells. J Gastroenterol 45: 52336.
  • 56
    Chockalingam K., Simeon R.L., Rice C.M., Chen Z. (2010) A cell protection screen reveals potent inhibitors of multiple stages of the hepatitis C virus life cycle. Proc Natl Acad Sci U S A 107: 37649.
  • 57
    Gastaminza P., Whitten-Bauer C., Chisari F.V. (2010) Unbiased probing of the entire hepatitis C virus life cycle identifies clinical compounds that target multiple aspects of the infection. Proc Natl Acad Sci U S A 107: 2916.
  • 58
    Rakic B., Sagan S.M., Noestheden M., Belanger S., Nan X., Evans C.L., Xie X.S., Pezacki J.P. (2006) Peroxisome proliferator-activated receptor alpha antagonism inhibits hepatitis C virus replication. Chem Biol 13: 2330.
  • 59
    Bukh J. (2004) A critical role for the chimpanzee model in the study of hepatitis C. Hepatology 39: 146975.
  • 60
    Heckel J.L., Sandgren E.P., Degen J.L., Palmiter R.D., Brinster R.L. (1990) Neonatal bleeding in transgenic mice expressing urokinase-type plasminogen activator. Cell 62: 44756.
  • 61
    Mercer D.F., Schiller D.E., Elliott J.F., Douglas D.N., Hao C., Rinfret A., Addison W.R., Fischer K.P., Churchill T.A., Lakey J.R., Tyrrell D.L., Kneteman N.M. (2001) Hepatitis C virus replication in mice with chimeric human livers. Nat Med 7: 92733.
  • 62
    Tateno C., Yoshizane Y., Saito N., Kataoka M., Utoh R., Yamasaki C., Tachibana A., Soeno Y., Asahina K., Hino H., Asahara T., Yokoi T., Furukawa T., Yoshizato K. (2004) Near completely humanized liver in mice shows human-type metabolic responses to drugs. Am J Pathol 165: 90112.
  • 63
    Diamond M.S. (2009) Mechanisms of evasion of the type I interferon antiviral response by flaviviruses. J Interferon Cytokine Res 29: 52130.
  • 64
    O'neill L.A., Bowie A.G. (2010) Sensing and signaling in antiviral innate immunity. Curr Biol 20: R32833.
  • 65
    Platanias L.C. (2005) Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol 5: 37586.
  • 66
    Tanaka Y., Nishida N., Sugiyama M., Kurosaki M., Matsuura K., Sakamoto N., Nakagawa M., Korenaga M., Hino K., Hige S., Ito Y., Mita E., Tanaka E., Mochida S., Murawaki Y., Honda M., Sakai A., Hiasa Y., Nishiguchi S., Koike A., Sakaida I., Imamura M., Ito K., Yano K., Masaki N., Sugauchi F., Izumi N., Tokunaga K., Mizokami M. (2009) Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet 41: 11059.
  • 67
    Thompson A.J., Muir A.J., Sulkowski M.S., Ge D., Fellay J., Shianna K.V., Urban T., Afdhal N.H., Jacobson I.M., Esteban R., Poordad F., Lawitz E.J., Mccone J., Shiffman M.L., Galler G.W., Lee W.M., Reindollar R., King J.W., Kwo P.Y., Ghalib R.H., Freilich B., Nyberg L.M., Zeuzem S., Poynard T., Vock D.M., Pieper K.S., Patel K., Tillmann H.L., Noviello S., Koury K., Pedicone L.D., Brass C.A., Albrecht J.K., Goldstein D.B., Mchutchison J.G. (2010) Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus. Gastroenterology 139: 120–9 e18.
  • 68
    Sumpter R., Jr., Loo Y.M. Foy E., Li K., Yoneyama M., Fujita T., Lemon S.M., Gale M., Jr. (2005) Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. J Virol 79: 268999.
  • 69
    Foy E., Li K., Sumpter R., Jr., Loo Y.M., Johnson C.L., Wang C., Fish P.M., Yoneyama M., Fujita T., Lemon S.M., Gale M., Jr. (2005) Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling. Proc Natl Acad Sci U S A 102: 298691.
  • 70
    Aly H.H., Oshiumi H., Shime H., Matsumoto M., Wakita T., Shimotohno K., Seya T. (2011) Development of mouse hepatocyte lines permissive for hepatitis C virus (HCV). PLoS One 6: e21284.
  • 71
    Lin L.T., Noyce R.S., Pham T.N., Wilson J.A., Sisson G.R., Michalak T.I., Mossman K.L., Richardson C.D. (2010) Replication of subgenomic hepatitis C virus replicons in mouse fibroblasts is facilitated by deletion of interferon regulatory factor 3 and expression of liver-specific microRNA 122. J Virol 84: 917080.